Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Sales | 4,202 | 18,690 | 10,035 | 5,685 | 3,131 |
| Cost of Goods | N/A | N/A | N/A | 0 | 350 |
| Gross Profit | N/A | N/A | N/A | 5,685 | 2,781 |
| Operating Expenses | 35,182 | 37,253 | 29,817 | 14,010 | 9,958 |
| Operating Income | -30,980 | -18,563 | -19,782 | -8,325 | -7,177 |
| Interest Expense | 1,801 | 1,725 | 1,711 | 974 | 102 |
| Other Income | -7 | 2,484 | 50 | 131 | 944 |
| Pre-tax Income | -32,788 | -17,804 | -21,443 | -9,168 | -6,335 |
| Income Tax | 368 | 201 | 133 | 45 | -2,017 |
| Net Income Continuous | -33,156 | -18,005 | -21,576 | -9,213 | -4,318 |
| Net Income | $-33,156 | $-18,005 | $-21,576 | $-9,213 | $-4,318 |
| EPS Basic Total Ops | -0.10 | -0.06 | -0.08 | -0.05 | -0.03 |
| EPS Basic Continuous Ops | -0.10 | -0.06 | -0.08 | -0.05 | -0.03 |
| EPS Diluted Total Ops | -0.10 | -0.06 | -0.08 | -0.05 | -0.03 |
| EPS Diluted Continuous Ops | -0.10 | -0.06 | -0.08 | -0.05 | -0.03 |
| EBITDA(a) | $-30,027 | $-15,193 | $-19,099 | $-7,529 | $-6,142 |